To apply for Class D medical device registration in Saudi Arabia, manufacturers and their appointed representatives must meet specific regulatory, technical, quality, and administrative conditions set by the Saudi Food and Drug Authority (SFDA). These conditions ensure that high-risk (Class D) devices—such as implants, life-support systems, and invasive devices—are safe, effective, and compliant with local laws.
Here is a detailed breakdown of the key conditions that must be met before applying for Class D medical device registration in Saudi Arabia:
You must classify the device according to SFDA’s classification rules, which are aligned with IMDRF/GHTF frameworks.
Class D typically includes:
Implantable devices (e.g. orthopedic, cardiovascular)
Life-supporting equipment (e.g. ventilators, pacemakers)
Critical diagnostic devices (e.g. IVDs for HIV, blood grouping)
Provide classification rationale using SFDA's risk-based criteria.
Foreign manufacturers are required to appoint a Saudi-based LAR.
The LAR must be:
A legally registered Saudi company
Licensed by SFDA
Holding a valid Establishment License (EL)
The LAR is responsible for:
Submitting applications
Communicating with SFDA
Handling post-market surveillance
Before applying for product registration, both the manufacturer and the LAR must obtain an Establishment License via SFDA’s GHAD platform.
Requirements include:
Valid Commercial Registration (CR)
ISO 13485 certificate (for manufacturer)
Signed LAR agreement or appointment letter
QMS documentation (if requested)
📌 GHAD Portal: https://ghad.sfda.gov.sa
The manufacturer must have a valid ISO 13485:2016 certificate issued by an SFDA-recognized certification body.
Certificate must:
Cover the relevant manufacturing site(s)
Be valid on the date of application
Include the scope that covers the device in question
You must prepare and submit a complete technical dossier, which includes:
General product description
Design verification and validation
Risk management report (ISO 14971)
Clinical Evaluation Report (CER)
Biocompatibility, sterilization, and software validation (if applicable)
Product labels and Instructions for Use (IFU) in Arabic and English
You must demonstrate that the device has been legally marketed or approved in other recognized markets:
Acceptable evidence includes:
CE certificate under EU MDR (preferred)
FDA 510(k) or PMA approval
Certificate of Free Sale (CFS) from country of origin
Declaration of Conformity (DoC) signed by manufacturer
Market history of the device
Devices without existing approvals may be subject to enhanced clinical scrutiny or local trials.
All packaging, labels, and Instructions for Use (IFU) must be provided in both Arabic and English and comply with SFDA requirements, including:
Product name and model
Manufacturer and LAR information
Expiry date, batch/lot number
Storage conditions
Warnings and symbols
A full Clinical Evaluation Report (CER) is mandatory for Class D devices.
CER should be based on:
Literature review
Clinical investigation results (if applicable)
Post-market clinical follow-up (PMCF) data
SFDA may request additional clinical data or trials, especially for new or novel devices.
The applicant must have valid access to:
MDNR for device registration: https://mdnr.sfda.gov.sa
GHAD for Establishment Licensing: https://ghad.sfda.gov.sa
The account must be linked to the LAR's licensed company.
SFDA requires a plan for vigilance and post-market monitoring. Before registration:
Prepare a PMS plan
Be ready to report adverse events, recalls, or Field Safety Corrective Actions (FSCA)
Maintain traceability and complaint handling procedures
Applicable fees for Class D registration must be paid before the application is reviewed:
| Fee Type | Estimated Range |
|---|---|
| Class D Registration Fee | SAR 25,000–40,000 |
| Establishment License (EL) Fee | SAR 10,000–15,000 |
| Additional testing (if needed) | Varies per product |
| Requirement | Class D Expectation |
|---|---|
| Device Classification | Must meet SFDA Class D risk criteria |
| Local Authorized Representative (LAR) | Required for foreign manufacturers |
| Establishment License | Mandatory for both LAR and manufacturer |
| ISO 13485 Certificate | Valid, SFDA-recognized certification |
| Technical Documentation | Full design dossier + supporting studies |
| Clinical Evaluation | Comprehensive CER with strong evidence |
| Labeling and IFU | Arabic + English, SFDA-compliant |
| CE/FDA/CFS/DoC | Required as regulatory evidence |
| PMS and Vigilance Plan | Must be prepared and maintained |
| MDNR and GHAD Access | Accounts and login credentials for portals |
Confirm device classification under SFDA guidelines
Appoint an LAR and register them on GHAD
Obtain Establishment License for manufacturer and LAR
Prepare a compliant dossier
Submit via MDNR portal
.jpg)
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn